NeoTRACK trial: neoadjuvant TiRagolumab, Atezolizumab and Chemotherapy : dissection of IO- efficacy in NSCLC by longitudinal tracKing : protocol of a non-randomised, open-label, single-arm, phase II study - Rösch, Romina M.; Schnorbach, Johannes; Klotz, Laura Valentina; Griffo, Raffaella; Thomas, Michael; Stenzinger, Albrecht; Christopoulos, Petros; Allgäuer, Michael; Schneider, Marc; Schuler, Martin; Wiesweg, Marcel; Schramm, Alexander; et al. (BMJ open, 2025)
Im Titelzusatz sind unterstrichen: neo in neoadjuvant, T und R in TiRagolumab, A in Atezolizumab, C in chemotherapy und K in tracKing